Integrated chromatin and transcriptomic profiling of patient-derived colon cancer organoids identifies personalized drug targets to overcome oxaliplatin resistance

Siegel, 2019, Cancer statistics, 2019, CA A Cancer J Clin, 69, 7, 10.3322/caac.21551 Siegel, 2018, Cancer statistics, CA A Cancer J Clin, 68, 7, 10.3322/caac.21442 2019 Manfredi, 2006, Epidemiology and management of liver metastases from colorectal cancer, Ann Surg, 244, 254, 10.1097/01.sla.0000217629.94941.cf Chang, 2007, Lymph node evaluation and survival after curative resection of colon cancer: systematic review, J Natl Cancer Inst, 99, 433, 10.1093/jnci/djk092 Dashwood, 1999, Early detection and prevention of colorectal cancer (review), Oncol Rep, 6, 277 Longley, 2005, Molecular mechanisms of drug resistance, J Pathol, 205, 275, 10.1002/path.1706 Comella, 2009, Role of oxaliplatin in the treatment of colorectal cancer, Ther Clin Risk Manag, 5, 229, 10.2147/TCRM.S3583 Siegel, 2014, Colorectal cancer statistics, CA A Cancer J Clin, 64, 104, 10.3322/caac.21220 Seruga, 2015, Failures in phase III: causes and consequences, Clin Cancer Res, 21, 4552, 10.1158/1078-0432.CCR-15-0124 Miranda, 2018, Towards multi-organoid systems for drug screening applications, Bioengineering, 5, 10.3390/bioengineering5030049 Clevers, 2016, Modeling development and disease with organoids, Cell, 165, 1586, 10.1016/j.cell.2016.05.082 Sato, 2011, Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium, Gastroenterology, 141, 1762, 10.1053/j.gastro.2011.07.050 Lancaster, 2014, Organogenesis in a dish: modeling development and disease using organoid technologies, Science, 345, 10.1126/science.1247125 Bu, 2016, A miR-34a-Numb feedforward loop triggered by inflammation regulates asymmetric stem cell division in intestine and colon cancer, Cell Stem Cell, 18, 189, 10.1016/j.stem.2016.01.006 Buzzelli, 2018, Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance, Stem Cell Res, 27, 109, 10.1016/j.scr.2018.01.016 Weeber, 2017, Tumor organoids as a pre-clinical cancer model for drug discovery, Cell Chem Biol, 24, 1092, 10.1016/j.chembiol.2017.06.012 Skardal, 2015, Liver-tumor hybrid organoids for modeling tumor growth and drug response in vitro, Ann Biomed Eng, 43, 2361, 10.1007/s10439-015-1298-3 Vlachogiannis, 2018, Patient-derived organoids model treatment response of metastatic gastrointestinal cancers, Science, 359, 920, 10.1126/science.aao2774 Crea, 2011, Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies, Drug Resist Updates, 14, 280, 10.1016/j.drup.2011.08.001 Glaser, 2003, Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines, Mol Cancer Ther, 2, 151 Flis, 2010, MS275 enhances cytotoxicity induced by 5-fluorouracil in the colorectal cancer cells, Eur J Pharmacol, 627, 26, 10.1016/j.ejphar.2009.10.033 Fazzone, 2009, Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells, Int J Cancer, 125, 463, 10.1002/ijc.24403 Tumber, 2007, The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo, Cancer Chemother Pharmacol, 60, 275, 10.1007/s00280-006-0374-7 Lee, 2006, Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells, Mol Cancer Ther, 5, 3085, 10.1158/1535-7163.MCT-06-0419 Gagnon, 2006, Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer, Clin Cancer Res, 12, 1850, 10.1158/1078-0432.CCR-05-2130 Hauswald, 2009, Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes, Clin Cancer Res, 15, 3705, 10.1158/1078-0432.CCR-08-2048 Innocenti, 2009, Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics, J Clin Oncol: Off J Am Soc Clin Oncol, 27, 2604, 10.1200/JCO.2008.20.6300 Chang, 2010, Identification of hypermethylated genes associated with cisplatin resistance in human cancers, Cancer Res, 70, 2870, 10.1158/0008-5472.CAN-09-3427 Chen, 2014, Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression, Hepatology, 60, 598, 10.1002/hep.27118 Cassoni, 2004, Oxytocin and oxytocin receptors in cancer cells and proliferation, J Neuroendocrinol, 16, 362, 10.1111/j.0953-8194.2004.01165.x Corces, 2017, An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues, Nat Methods, 14, 959, 10.1038/nmeth.4396 Kim, 2015, HISAT: a fast spliced aligner with low memory requirements, Nat Methods, 12, 357, 10.1038/nmeth.3317 Langmead, 2012, Fast gapped-read alignment with Bowtie 2, Nat Methods, 9, 357, 10.1038/nmeth.1923 Liu, 2014, Use model-based Analysis of ChIP-Seq (MACS) to analyze short reads generated by sequencing protein-DNA interactions in embryonic stem cells, Methods Mol Biol, 1150, 81, 10.1007/978-1-4939-0512-6_4 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, 15, 10.1186/s13059-014-0550-8 Ross-Innes, 2012, Differential oestrogen receptor binding is associated with clinical outcome in breast cancer, Nature, 481, 389, 10.1038/nature10730 Heinz, 2010, Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities, Mol Cell, 38, 576, 10.1016/j.molcel.2010.05.004 Ramirez, 2016, Deep tools2: a next generation web server for deep-sequencing data analysis, Nucleic Acids Res, 44, W160, 10.1093/nar/gkw257 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, 102, 15545, 10.1073/pnas.0506580102 Segal, 2004, A module map showing conditional activity of expression modules in cancer, Nat Genet, 36, 1090, 10.1038/ng1434 Cotto, 2018, DGIdb 3.0: a redesign and expansion of the drug-gene interaction database, Nucleic Acids Res, 46, D1068, 10.1093/nar/gkx1143 Farre, 2003, Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN, Nucleic Acids Res, 31, 3651, 10.1093/nar/gkg605 Daily, 2011, MotifMap: integrative genome-wide maps of regulatory motif sites for model species, BMC Bioinf, 12, 10.1186/1471-2105-12-495 Tommasi, 2011, Oncosuppressor methylation: a possible key role in colon metastatic progression, J Cell Physiol, 226, 1934, 10.1002/jcp.22524 Youssef, 2004, Methylation and regulation of expression of different retinoic acid receptor beta isoforms in human colon cancer, Cancer Biol Ther, 3, 82, 10.4161/cbt.3.1.591 Stewart, 1997, Retinoids differentially regulate the proliferation of colon cancer cell lines, Exp Cell Res, 233, 321, 10.1006/excr.1997.3569 Selaru, 2009, Epigenetic events in gastrointestinal cancer, Am J Gastroenterol, 104, 1910, 10.1038/ajg.2008.145 Romero-Calvo, 2019, Human organoids share structural and genetic features with primary pancreatic adenocarcinoma tumors, Mol Cancer Res, 17, 70, 10.1158/1541-7786.MCR-18-0531 Nagle, 2018, Patient-derived tumor organoids for prediction of cancer treatment response, Semin Cancer Biol, 53, 258, 10.1016/j.semcancer.2018.06.005 Mazzocchi, 2018, In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening, Sci Rep, 8, 10.1038/s41598-018-21200-8 Walsh, 2016, Drug response in organoids generated from frozen primary tumor tissues, Sci Rep, 6, 10.1038/srep18889 Turner, 2010, FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer, Cancer Res, 70, 2085, 10.1158/0008-5472.CAN-09-3746 Malchers, 2017, Mechanisms of primary drug resistance in FGFR1-amplified lung cancer, Clin Cancer Res, 23, 5527, 10.1158/1078-0432.CCR-17-0478 Heist, 2012, FGFR1 amplification in squamous cell carcinoma of the lung, J Thorac Oncol, 7, 1775, 10.1097/JTO.0b013e31826aed28 Ariana, 2019, Preventive effects of oxytocin and oxytocin receptor in breast cancer pathogenesis, Personalized Med, 16, 25, 10.2217/pme-2018-0009 Zhong, 2010, Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway, Mol Cancer Res, 8, 1164, 10.1158/1541-7786.MCR-09-0329